IP Library Granted Patent US 8,206,921
Granted Patent B2
US 8,206,921 · App. 12/620,187 · Granted Jun 26, 2012

Detection of methicillin-resistant

Assignee: AdvanDx, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,206,921
App. No.
12/620,187
Granted
Jun 26, 2012
Kind
B2
Abstract

This invention relates to the use of genetic probes for detection of the presence of the SCCmec cassette in Staphylococcus aureus . In one aspect, the invention allows specific detection and identification of methicillin-resistant S. aureus (MRSA) in a clinical sample without interference from the presence of other non- S. aureus methicillin-resistant staphylococci. In another aspect, the invention allows specific detection and identification of methicillin-resistant coagulase negative staphylococci (MRCNS) originating from a clinical sample without interference from the presence of methicillin-resistant S. aureus.

Claims (17)

1. A method of testing a sample for the presence or absence of SCCmec cassette DNA in DNA of Staphylococcus aureus , the method comprising:

a) hybridizing the sample to one or more capture probes that hybridize to DNA of Staphylococcus aureus and one or more other species of staphylococci external to SCCmec cassette DNA, the capture probes optionally attached to a support;

b) hybridizing the sample to one or more blocker probes that hybridize to DNA of one or more other species of staphylococci;

c) hybridizing the sample to one or more detector probes that hybridize to SCCmec cassette DNA; and

d) detecting or not detecting each of the detector probes, thereby determining the presence or absence, respectively, of the SCCmec cassette DNA in the DNA of the Staphylococcus aureus,

wherein the one or more capture probes include a capture probe that comprises SEQ ID NO:5; wherein the one or more detector probes include a detector probe comprising SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:20, SEQ ID NO:21 or SEQ ID NO:22; and wherein the one or more blocker probes include a blocker probe comprising SEQ ID NO:14, SEQ ID NO:15 or SEQ ID NO:16.

2. A method of testing a sample for the presence or absence of SCCmec cassette DNA in DNA of a plurality of Staphylococcus species, the method comprising:

a) hybridizing the sample to one or more capture probes that hybridize to DNA of a plurality of Staphylococcus species external to SCCmec cassette DNA, the capture probes optionally attached to a support;

b) hybridizing the sample to one or more blocker probes that hybridize to the DNA of one or more of the plurality of Staphylococcus species;

c) hybridizing the sample to one or more detector probes that hybridize to SCCmec cassette DNA; and

d) detecting or not detecting each of the detector probes, thereby determining the presence or absence, respectively, of the SCCmec cassette DNA in the DNA of the plurality of Staphylococcus species;

wherein the one or more capture probes include a capture probe that comprises SEQ ID NO:5; wherein the one or more detector probes include a detector probe comprising SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:20, SEQ ID NO:21 or SEQ ID NO:22; and wherein the one or more blocker probes include a blocker probe comprising SEQ ID NO:14, SEQ ID NO:15 or SEQ ID NO:16.

3. A method of testing a sample for the presence or absence of SCCmec cassette DNA in DNA of Staphylococcus aureus , the method comprising:

a) hybridizing the sample to a capture probe that comprises SEQ ID NO:5, wherein the capture probe is optionally attached to a support;

b) hybridizing the sample to two or more blocker probes that hybridize to DNA of one or more other species of staphylococci, wherein the two or more blocker probes include a blocker probe comprising SEQ ID NO:14 and a blocker probe comprising SEQ ID NO:15;

c) hybridizing the sample to one or more detector probes that hybridize to SCCmec cassette DNA; and

d) detecting or not detecting each of the detector probes, thereby determining the presence or absence, respectively, of the SCCmec cassette DNA in the DNA of the Staphylococcus aureus.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Feb 3, 2021
From: MERCK GLOBAL HEALTH INNOVATION FUND, LLC
To: OPGEN, INC.; ADVANDX, INC.
Reel/Frame 055209/0242 →
SECURITY INTEREST Recorded Aug 17, 2015
From: OPGEN, INC.; ADVANDX, INC.
To: MERCK GLOBAL HEALTH INNOVATION FUND, LLC
Reel/Frame 036377/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2010
From: STENDER, HENRIK; RASMUSSEN, ANNE KARIN ILDOR; FIANDACA, MARK J.
To: ADVANDX, INC.
Reel/Frame 024049/0372 →
Continuity (3)
Continuation PCTUS2008006285 · May 16, 2008
Provisional Application 60930840 · May 18, 2007
Related Publication 20100143923A1 · Jun 10, 2010